Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
Published Online: 2020-07-?
Journal: The Lancet Infectious Diseases•Publisher: Elsevier BV
Authors: Adrian Hill•Alexandra Kupke•Alison Lawrie•Amy Boyd•Amy Flaxman•Catherine Mair•Cornelius Rohde•Daniel Silman•Duncan Bellamy•Eleanor Berrie•Fernando Ramos Lopez•Ian Poulton•Jae-Ouk Kim•Jonathan Sheridan•Julia Marshall•Katie Ewer•Manki Song•Mehreen Datoo•Mustapha Bittaye•Nguyen Tran•Pedro M Folegatti•Rachel Roberts•Rebecca Makinson•Sandro Halwe•Sarah Gilbert•Stephan Becker•Teresa Lambe•Young-Shin Park•Yrene Themistocleous•Yuji Jeong